- Home
- LITB vs LSTA Comparison
LITB vs LSTA Comparison
Compare LITB & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LITB
- LSTA
- Stock Information
- Founded
- LITB 2007
- LSTA 1980
- Country
- LITB Singapore
- LSTA United States
- Employees
- LITB N/A
- LSTA N/A
- Industry
- LITB Catalog/Specialty Distribution
- LSTA Misc Health and Biotechnology Services
- Sector
- LITB Consumer Discretionary
- LSTA Health Care
- Exchange
- LITB Nasdaq
- LSTA Nasdaq
- Market Cap
- LITB N/A
- LSTA 20.0M
- IPO Year
- LITB N/A
- LSTA N/A
- Fundamental
- Price
- LITB $1.00
- LSTA $2.27
- Analyst Decision
- LITB
- LSTA Strong Buy
- Analyst Count
- LITB 0
- LSTA 1
- Target Price
- LITB N/A
- LSTA $15.00
- AVG Volume (30 Days)
- LITB 21.3K
- LSTA 17.1K
- Earning Date
- LITB 03-24-2025
- LSTA 02-27-2025
- Dividend Yield
- LITB N/A
- LSTA N/A
- EPS Growth
- LITB N/A
- LSTA N/A
- EPS
- LITB N/A
- LSTA N/A
- Revenue
- LITB $333,093,000.00
- LSTA $1,000,000.00
- Revenue This Year
- LITB N/A
- LSTA N/A
- Revenue Next Year
- LITB N/A
- LSTA N/A
- P/E Ratio
- LITB N/A
- LSTA N/A
- Revenue Growth
- LITB N/A
- LSTA N/A
- 52 Week Low
- LITB $0.91
- LSTA $2.05
- 52 Week High
- LITB $6.00
- LSTA $4.20
- Technical
- Relative Strength Index (RSI)
- LITB 39.53
- LSTA 38.28
- Support Level
- LITB $0.92
- LSTA $2.05
- Resistance Level
- LITB $1.05
- LSTA $2.46
- Average True Range (ATR)
- LITB 0.06
- LSTA 0.20
- MACD
- LITB 0.01
- LSTA 0.01
- Stochastic Oscillator
- LITB 26.92
- LSTA 32.81
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.